Literature DB >> 17013564

The E-site story: the importance of maintaining two tRNAs on the ribosome during protein synthesis.

D N Wilson1, K H Nierhaus.   

Abstract

In the sixties James Watson suggested a twosite model for the ribosome comprising the P site for the peptidyl transfer RNA (tRNA) before peptide-bond formation and the A site, where decoding takes place according to the codon exposed there. In the eighties a third tRNA binding site was detected, the E site, which was specific for deacylated tRNA and turned out to be a universal feature of ribosomes. However, despite having three tRNA binding sites, only two tRNAs occupy the ribosome at a time during protein synthesis: at the A and P sites before translocation (PRE state) and at the P and E sites after translocation (POST state). The importance of having two tRNAs in the POST state has been revealed during the last 25 years, showing that the E site contributes two fundamental features: (i) the fact that incorporation of a wrong amino acid is not harmful for the cell (only 1 in about 400 misincorporations destroys the function of a protein) stems from the presence of an E-tRNA; (ii) maintenance of the reading frame is one of the most remarkable achievements of the ribosome, essential for faithful translation of the genetic information. The presence of the POST state E-tRNA prevents loss of the reading frame.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17013564     DOI: 10.1007/s00018-006-6125-4

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  30 in total

1.  Allosteric vs. spontaneous exit-site (E-site) tRNA dissociation early in protein synthesis.

Authors:  Chunlai Chen; Benjamin Stevens; Jaskiran Kaur; Zeev Smilansky; Barry S Cooperman; Yale E Goldman
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-03       Impact factor: 11.205

2.  The transition from noncoded to coded protein synthesis: did coding mRNAs arise from stability-enhancing binding partners to tRNA?

Authors:  Harold Stephen Bernhardt; Warren Perry Tate
Journal:  Biol Direct       Date:  2010-04-09       Impact factor: 4.540

3.  Biocrystallography: past, present, future.

Authors:  Richard Giegé; Claude Sauter
Journal:  HFSP J       Date:  2010-04-22

4.  Selenocysteine insertion sequence (SECIS)-binding protein 2 alters conformational dynamics of residues involved in tRNA accommodation in 80 S ribosomes.

Authors:  Kelvin Caban; Paul R Copeland
Journal:  J Biol Chem       Date:  2012-02-03       Impact factor: 5.157

5.  Codon-Anticodon Recognition in the Bacillus subtilis glyQS T Box Riboswitch: RNA-DEPENDENT CODON SELECTION OUTSIDE THE RIBOSOME.

Authors:  Enrico Caserta; Liang-Chun Liu; Frank J Grundy; Tina M Henkin
Journal:  J Biol Chem       Date:  2015-07-30       Impact factor: 5.157

6.  Genetic analysis of the E site during RF2 programmed frameshifting.

Authors:  Christina L Sanders; James F Curran
Journal:  RNA       Date:  2007-07-27       Impact factor: 4.942

7.  A role for the 30S subunit E site in maintenance of the translational reading frame.

Authors:  Aishwarya Devaraj; Shinichiro Shoji; Eric D Holbrook; Kurt Fredrick
Journal:  RNA       Date:  2008-12-17       Impact factor: 4.942

Review 8.  A gripping tale of ribosomal frameshifting: extragenic suppressors of frameshift mutations spotlight P-site realignment.

Authors:  John F Atkins; Glenn R Björk
Journal:  Microbiol Mol Biol Rev       Date:  2009-03       Impact factor: 11.056

9.  Shine-Dalgarno interaction prevents incorporation of noncognate amino acids at the codon following the AUG.

Authors:  Viviana Di Giacco; Viter Márquez; Yan Qin; Markus Pech; Francisco J Triana-Alonso; Daniel N Wilson; Knud H Nierhaus
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-30       Impact factor: 11.205

10.  Translational bypassing without peptidyl-tRNA anticodon scanning of coding gap mRNA.

Authors:  Norma M Wills; Michelle O'Connor; Chad C Nelson; Charles C Rettberg; Wai Mun Huang; Raymond F Gesteland; John F Atkins
Journal:  EMBO J       Date:  2008-09-04       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.